Pranidipine Enhances the Action of Nitric Oxide Released From Endothelial Cells

Nitric oxide (NO) synthesis in vascular endothelium of patients with hypertension is altered. Calcium antagonists have been shown to improve endothelial function in hypertensive patients. Here we report that pranidipine, one of the latest long-acting calcium antagonists in the dihydropyridine group,...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Hypertension (Dallas, Tex. 1979) Tex. 1979), 2000-01, Vol.35 (1, Part 1), p.82-82
Hauptverfasser:	Yang, Jin, Fukuo, Keisuke, Morimoto, Shigeto, Niinobu, Tadaaki, Suhara, Toshimitsu, Ogihara, Toshio
Format:	Artikel
Sprache:	eng
Schlagworte:	Amlodipine - pharmacology Animals Antihypertensive agents Aorta, Thoracic - drug effects Aorta, Thoracic - metabolism Biological and medical sciences Calcium Channel Blockers - pharmacology Cardiovascular system Cells, Cultured Coculture Techniques Cyclic GMP - metabolism Dihydropyridines - pharmacology Endothelin-1 - biosynthesis Endothelium, Vascular - drug effects Endothelium, Vascular - metabolism Humans Hypertension - drug therapy Hypertension - metabolism Male Medical sciences Muscle, Smooth, Vascular - drug effects Muscle, Smooth, Vascular - metabolism Nifedipine - pharmacology Nitric Oxide - biosynthesis Nitric Oxide Synthase - metabolism Nitric Oxide Synthase Type III Pharmacology. Drug treatments Rats Rats, Wistar Superoxide Dismutase - metabolism
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!